Sylvain Williams pursues several complimentary lines of study aimed towards elucidating the cause of Alzheimer Disease.

Gustavo Turecki investigates the neurobiology of suicide, focusing on the role of genetic risk factors.

Judes Poirier who had discovered a novel genetic risk factor that triggers the common form of Alzheimer’s disease, again made history in June.  

Pedro Rosa-Neto is interested in the structural changes that occur in the brain as a result of neurodegenerative disease.

Salah El Mestikawy studies neurons using glutamate as a neurotransmitter in healthy and diseased central nervous systems.  

Michel Perreault's main focus is the evaluation of psychiatric and substance abuse programs.  

Eric Latimer, PhD, is a health economist and looks for ways to improve the services to people with severe forms of mental illness.

N.P. Vasavan Nair, M.D., FRCPC, has contributed to the Douglas Institute in a variety of capacities.

Alain Brunet, PhD, studies risk factors and develops effective treatments for PTSD, such as early intervention and reconsolidation blockade.

Alain Gratton, PhD, investigates the role of dopamine in drug abuse, as well as exposure to stress.